Joe Haydamous (20886605)

No ORCID on file · 6 papers in corpus · active 2025

Study types

  • dataset 6

Condition tags

  • adenomyosis 6
dataset 2025
·doi:10.3389/fendo.2025.1571727.s005

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s006

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s001

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s002

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s003

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …

dataset 2025
·doi:10.3389/fendo.2025.1571727.s004

Background To date, there are no clear guidelines available on the treatment of adenomyosis-associated pelvic pain (AAPP); however, numerous hormonal treatments (HTs) are currently being used off-label. We conducted a systematic review and …